Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 545068, 6 pages
http://dx.doi.org/10.1155/2015/545068
Research Article

Total and High Molecular Weight Adiponectin Levels and Prediction of Cardiovascular Risk in Diabetic Patients

1Department of Preventive Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic
2Clinic of Internal Medicine, University Hospital Ostrava, 17. Listopadu 1790, 708 52 Ostrava-Poruba, Czech Republic
3Department of Sports and Exercise Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, I.P. Pavlova 6, 775 15 Olomouc, Czech Republic
4Department of Clinical Biochemistry and Immunogenetics, University Hospital Olomouc, I.P. Pavlova 6, 775 15 Olomouc, Czech Republic
5Department of Clinical Biochemistry, University Hospital Ostrava, 17. Listopadu 1790, 708 52 Ostrava-Poruba, Czech Republic
6Department of Respiratory Medicine, University Hospital Olomouc, I.P. Pavlova 6, 775 15 Olomouc, Czech Republic
7Department of Transfusion Medicine, University Hospital Olomouc, I.P. Pavlova 6, 775 15 Olomouc, Czech Republic
8Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15 Olomouc, Czech Republic

Received 2 December 2014; Accepted 23 April 2015

Academic Editor: Alexander Schreiber

Copyright © 2015 Dagmar Horáková et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Lim, M. J. Quon, and K. K. Koh, “Modulation of adiponectin as a potential therapeutic strategy,” Atherosclerosis, vol. 233, no. 2, pp. 721–728, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Li, T. Zhao, and X. Wen, “Changes in serum adiponectin concentrations and endothelial function after intensive insulin treatment in people with newly diagnosed type 2 diabetes: a pilot study,” Diabetes Research and Clinical Practice, vol. 94, no. 2, pp. 186–192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Pischon, F. B. Hu, C. J. Girman et al., “Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women,” Atherosclerosis, vol. 219, no. 1, pp. 322–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Zhang, X. Mo, Y. Hao et al., “Adiponectin levels and risk of coronary heart disease: a meta-analysis of prospective studies,” The American Journal of the Medical Sciences, vol. 345, no. 6, pp. 455–461, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. K. J. Mather and R. B. Goldberg, “Clinical use of adiponectin as a marker of metabolic dysregulation,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 28, no. 1, pp. 107–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Yadav, M. A. Kataria, and V. Saini, “Role of leptin and adiponectin in insulin resistance,” Clinica Chimica Acta, vol. 417, pp. 80–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Wang, W. Xing, H. Zhang et al., “Reduced high-molecular-weight adiponectin is an independent risk factor for cardiovascular lesions in hypercholesterolaemic patients,” Clinical Endocrinology, vol. 78, no. 4, pp. 539–544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe, “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1784–1792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Devaraj, M. M. Swarbrick, U. Singh, B. Adams-Huet, P. J. Havel, and I. Jialal, “CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers,” American Journal of Clinical Pathology, vol. 129, no. 5, pp. 815–822, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Oku, F. Matsuura, M. Koseki et al., “Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver,” FEBS Letters, vol. 581, no. 26, pp. 5029–5033, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Tsubakio-Yamamoto, F. Matsuura, M. Koseki et al., “Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages,” Biochemical and Biophysical Research Communications, vol. 375, no. 3, pp. 390–394, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Saito, K. Yamagishi, C.-L. Chei et al., “Total and high molecular weight adiponectin levels and risk of cardiovascular disease in individuals with high blood glucose levels,” Atherosclerosis, vol. 229, no. 1, pp. 222–227, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Luo, H. Lei, and Q. Liu, “Correlation between serum adiponectin and risk factors in patients with coronary artery disease,” Clinical Laboratory, vol. 59, no. 1-2, pp. 121–126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. S. Lee, S.-S. Park, E. Kim et al., “Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis,” International Journal of Epidemiology, vol. 42, no. 4, Article ID dyt087, pp. 1029–1039, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Inoue, E. Maehata, M. Yano, M. Taniyama, and S. Suzuki, “Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes,” Metabolism: Clinical and Experimental, vol. 54, no. 3, pp. 281–286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. R. Langenfeld, T. Forst, E. Standl et al., “IRIS II study: sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistance,” Diabetes Technology and Therapeutics, vol. 6, no. 6, pp. 836–843, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. K. J. Mather, T. Funahashi, Y. Matsuzawa et al., “Adiponectin, change in adiponectin, and progression to diabetes in the diabetes prevention program,” Diabetes, vol. 57, no. 4, pp. 980–986, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. R. B. Goldberg, M. Temprosa, S. Haffner et al., “Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group,” Diabetes Care, vol. 32, no. 4, pp. 726–732, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. R. Cook and R. K. Semple, “Hypoadiponectinemia—cause or consequence of human ‘insulin resistance’?” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 4, pp. 1544–1554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Jotic, N. Covickovic Sternic, V. S. Kostic et al., “Type 2 diabetic patients with ischemic stroke: decreased insulin sensitivity and decreases in antioxidant enzyme activity are related to different stroke subtypes,” International Journal of Endocrinology, vol. 2013, Article ID 401609, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. Webb, K. Khunti, S. Chatterjee, J. Jarvis, and M. J. Davies, “Adipocytokine associations with insulin resistance in British south Asians,” Journal of Diabetes Research, vol. 2013, Article ID 561016, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Lindberg, J. S. Jensen, M. Bjerre et al., “Adiponectin, type 2 diabetes and cardiovascular risk,” European Journal of Preventive Cardiology, vol. 22, no. 3, pp. 276–283, 2015. View at Google Scholar
  23. E. S. Ford, “Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999–2008,” Journal of Diabetes, vol. 3, no. 4, pp. 337–347, 2011. View at Publisher · View at Google Scholar · View at Scopus